Correlation Between Navidea Biopharmaceutica and Upstream Bio,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Upstream Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Upstream Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Upstream Bio,, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Upstream Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Upstream Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Upstream Bio,.

Diversification Opportunities for Navidea Biopharmaceutica and Upstream Bio,

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Navidea and Upstream is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Upstream Bio, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Upstream Bio, and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Upstream Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Upstream Bio, has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Upstream Bio, go up and down completely randomly.

Pair Corralation between Navidea Biopharmaceutica and Upstream Bio,

If you would invest  1,700  in Upstream Bio, on September 28, 2024 and sell it today you would earn a total of  245.00  from holding Upstream Bio, or generate 14.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy1.85%
ValuesDaily Returns

Navidea Biopharmaceuticals  vs.  Upstream Bio,

 Performance 
       Timeline  
Navidea Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Upstream Bio, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Upstream Bio, sustained solid returns over the last few months and may actually be approaching a breakup point.

Navidea Biopharmaceutica and Upstream Bio, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Navidea Biopharmaceutica and Upstream Bio,

The main advantage of trading using opposite Navidea Biopharmaceutica and Upstream Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Upstream Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will offset losses from the drop in Upstream Bio,'s long position.
The idea behind Navidea Biopharmaceuticals and Upstream Bio, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data